BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

Bandaram Pharma Packtech Ltd. Share Price

NSE
BSE

BSE : 524602

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Day's Range

Low

High

Price Summary

Previous Close ₹18.50
Day's Range ₹18.50 - ₹18.69
Open ₹18.69
52 Week Range ₹17.45 - ₹49.70
Volume 2,712
Market Cap ₹0.00

Stocks Summary

Trade Value ( ₹ in Lacs) 0.50
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 0.00
Price/Earning (TTM) 74.98
TTM EPS (₹) 0.25
P/E Ratio 101.80
Book Value(₹) 1.25
PAT Margin (%) 2.69
Face Value (₹) 10.00
ROCE(%) 8.41

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 369.64 84.91
Expenses N/A N/A
PBT 13.16 2.0
Operating profit 0.0 0.0
Net profit 9.94 1.57

Shareholding Pattern

Promoters (% Holding)

62.66%

Mutual funds (% Holding)

0.00%

Non-Institution (% Holding)

37.33%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

0.00%

About Bandaram Pharma Packtech Ltd.

Founded 1993
Managing Director B Deepak Reddy

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd. 4,66,154.79 1,921.65 1,548.00 - 1,548.00
Divi's Laboratories Ltd. 2,25,648.29 8,533.50 5,636.50 - 5,636.50
Torrent Pharmaceuticals Ltd. 1,85,478.78 4,904.70 3,480.60 - 3,480.60
Apollo Hospitals Enterprise Ltd. 1,23,582.91 8,893.50 6,696.50 - 6,696.50
Cipla Ltd. 1,18,027.35 1,460.35 1,165.70 - 1,165.70
Zydus Lifesciences Ltd. 1,17,007.20 1,159.10 835.50 - 835.50
Lenskart Solutions Ltd. 1,03,767.01 607.00 0.00 - 0.00
Lupin Ltd. 1,03,380.81 2,241.55 1,875.00 - 1,875.00
Dr. Reddy's Laboratories Ltd. 1,00,661.90 1,198.90 1,101.00 - 1,101.00
Mankind Pharma Ltd. 99,862.43 2,445.00 1,909.70 - 1,909.70
no-content No Records Found

Latest News

Aug
14
2026
COMPANY Posted on Aug 14th 2026

Denis Chem Lab - Quaterly Results

A minor change in the total revenue was seen in the June 2026 quarter. The total revenue for the quarter stood at Rs. 439.97 millions against Rs. 432.76 millions during year ago period.The Company's Net profit for the June 2026 quarter have declined marginally to Rs. 20.44  millions as against Rs. 24.74 millions reported during the corresponding quarter ended.Operating Profit reported a sharp decline to 42.81 millions from 51.13 millions in the corresponding previous quarter.
(Rs. in Million)
  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 439.97 432.76 1.67 439.97 432.76 1.67 1817.20 1733.00 4.86
Other Income 4.50 3.00 50.00 4.50 3.00 50.00 19.23 23.74 -19.00
PBIDT 42.81 51.13 -16.27 42.81 51.13 -16.27 195.71 184.83 5.89
Interest 1.08 1.86 -41.94 1.08 1.86 -41.94 8.41 5.10 64.90
PBDT 41.73 49.27 -15.30 41.73 49.27 -15.30 187.30 179.73 4.21
Depreciation 15.30 16.12 -5.09 15.30 16.12 -5.09 68.36 68.61 -0.36
PBT 26.43 33.15 -20.27 26.43 33.15 -20.27 118.94 111.12 7.04
TAX 5.99 8.41 -28.78 5.99 8.41 -28.78 34.86 30.35 14.86
Deferred Tax 3.47 -0.92 -477.17 3.47 -0.92 -477.17 -3.68 -8.98 -59.02
PAT 20.44 24.74 -17.38 20.44 24.74 -17.38 84.08 80.77 4.10
Equity 138.77 138.77 0.00 138.77 138.77 0.00 138.77 138.77 0.00
PBIDTM(%) 9.73 11.81 -17.64 9.73 11.81 -17.64 10.77 10.67 0.98
Read More
Aug
14
2026
COMPANY Posted on Aug 14th 2026

Lincoln Pharma - Quaterly Results

The company witnessed a 15.07% growth in the revenue at Rs. 1772.82 millions for the quarter ended June 2026 as compared to Rs. 1540.67 millions during the year-ago period.An average growth of 30.93% was recorded for the quarter ended June 2026 to Rs. 362.34  millions from Rs. 276.75 millions.Operating profit surged to 516.96 millions from the corresponding previous quarter of 390.76 millions.
(Rs. in Million)
  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 1772.82 1540.67 15.07 1772.82 1540.67 15.07 6710.30 6232.30 7.67
Other Income 242.65 152.72 58.89 242.65 152.72 58.89 334.54 224.77 48.84
PBIDT 516.96 390.76 32.30 516.96 390.76 32.30 1311.37 1239.71 5.78
Interest 2.59 2.10 23.33 2.59 2.10 23.33 10.13 18.83 -46.20
PBDT 514.37 388.66 32.34 514.37 388.66 32.34 1301.24 1220.88 6.58
Depreciation 38.84 34.77 11.71 38.84 34.77 11.71 145.00 128.99 12.41
PBT 475.53 353.89 34.37 475.53 353.89 34.37 1156.24 1091.89 5.89
TAX 113.19 77.14 46.73 113.19 77.14 46.73 277.31 268.42 3.31
Deferred Tax 59.66 35.91 66.14 59.66 35.91 66.14 -0.31 15.15 -102.05
PAT 362.34 276.75 30.93 362.34 276.75 30.93 878.93 823.47 6.73
Equity 200.30 200.30 0.00 200.30 200.30 0.00 200.30 200.30 0.00
PBIDTM(%) 29.16 25.36 14.97 29.16 25.36 14.97 19.54 19.89 -1.76
Read More
Aug
14
2026
COMPANY Posted on Aug 14th 2026

Cresanto Global - Quaterly Results

A minor change in the total revenue was seen in the June 2026 quarter. The total revenue for the quarter stood at Rs. 0.00 millions against Rs. 0.00 millions during year ago period.The Net Loss for the quarter ended June 2026 is Rs. -0.59 millions as compared to Net Loss of Rs. -0.92 millions of corresponding quarter ended June 2025 Operating profit Margin for the quarter ended June 2026 improved to -0.59% as compared to -0.92% of corresponding quarter ended June 2025
(Rs. in Million)
  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.54 0.00 0.00
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.22 5.26 -95.82
PBIDT -0.59 -0.92 -35.87 -0.59 -0.92 -35.87 -2.71 -0.61 344.26
Interest 0.00 0.00 0.00 0.00 0.00 0.00 1.59 1.15 38.26
PBDT -0.59 -0.92 -35.87 -0.59 -0.92 -35.87 -4.30 -1.76 144.32
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.04 0.00
PBT -0.59 -0.92 -35.87 -0.59 -0.92 -35.87 -4.30 -1.80 138.89
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -0.59 -0.92 -35.87 -0.59 -0.92 -35.87 -4.30 -1.80 138.89
Equity 42.74 42.74 0.00 42.74 42.74 0.00 42.74 42.74 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 -501.85 0.00 0.00
Read More
Aug
14
2026
COMPANY Posted on Aug 14th 2026

Desh Rakshak Aushdh - Quaterly Results

The sales slipped to Rs. 8.28 millions, down -36.31% for the June 2026 quarter as against Rs. 13.00 millions during the year-ago period.Net profit declined -17.53% to Rs. 0.80 millions from Rs. 0.97 millions.Operating profit for the quarter ended June 2026 decreased to 2.43 millions as compared to 2.51 millions of corresponding quarter ended June 2025.
(Rs. in Million)
  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 8.28 13.00 -36.31 8.28 13.00 -36.31 71.04 62.71 13.28
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.11 0.33 -66.67
PBIDT 2.43 2.51 -3.19 2.43 2.51 -3.19 13.96 12.79 9.15
Interest 0.54 0.54 0.00 0.54 0.54 0.00 2.84 2.98 -4.70
PBDT 1.89 1.97 -4.06 1.89 1.97 -4.06 11.12 9.81 13.35
Depreciation 1.09 1.00 9.00 1.09 1.00 9.00 4.36 4.16 4.81
PBT 0.80 0.97 -17.53 0.80 0.97 -17.53 6.76 5.65 19.65
TAX 0.00 0.00 0.00 0.00 0.00 0.00 1.13 0.88 28.41
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 0.80 0.97 -17.53 0.80 0.97 -17.53 5.63 4.77 18.03
Equity 56.98 44.38 28.39 56.98 44.38 28.39 56.98 44.38 28.39
PBIDTM(%) 29.35 19.31 52.00 29.35 19.31 52.00 19.65 20.40 -3.65
Read More
Aug
14
2026
COMPANY Posted on Aug 14th 2026

Ipca Laboratories - Quaterly Results

The Revenue for the quarter ended  June 2026 of Rs. 21192.40 millions grew by 21.31 % from Rs. 17469.00 millions.A good growth in profit of 42.46% reported to Rs. 3732.90  millions over Rs. 2620.40 millions of corresponding previous quarter.Operating Profit saw a handsome growth to 5950.60 millions from 4319.40 millions in the quarter ended June 2026.
(Rs. in Million)
  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 21192.40 17469.00 21.31 21192.40 17469.00 21.31 73367.50 66779.20 9.87
Other Income 174.20 250.20 -30.38 174.20 250.20 -30.38 946.40 712.90 32.75
PBIDT 5950.60 4319.40 37.76 5950.60 4319.40 37.76 18749.30 15963.20 17.45
Interest 50.40 120.60 -58.21 50.40 120.60 -58.21 435.10 630.40 -30.98
PBDT 5900.20 4198.80 40.52 5900.20 4198.80 40.52 18010.00 12517.40 43.88
Depreciation 746.10 631.30 18.18 746.10 631.30 18.18 2688.70 2519.70 6.71
PBT 5154.10 3567.50 44.47 5154.10 3567.50 44.47 15321.30 9997.70 53.25
TAX 1421.20 947.10 50.06 1421.20 947.10 50.06 3996.10 3490.10 14.50
Deferred Tax 120.00 20.50 485.37 120.00 20.50 485.37 -25.10 81.10 -130.95
PAT 3732.90 2620.40 42.46 3732.90 2620.40 42.46 11325.20 6507.60 74.03
Equity 253.70 253.70 0.00 253.70 253.70 0.00 253.70 253.70 0.00
PBIDTM(%) 28.08 24.73 13.56 28.08 24.73 13.56 25.56 23.90 6.91
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Bandaram Pharma Packtech Ltd. ?

The current share price of Bandaram Pharma Packtech Ltd. is ₹18.50 as of 2026-08-14.

The market capitalisation of Bandaram Pharma Packtech Ltd. is ₹33.59 as of 2026-08-13.

The 1-year return of Bandaram Pharma Packtech Ltd. is -19.79% as of 2025-08-13.

The P/E ratio of Bandaram Pharma Packtech Ltd. is 101.80 as of 2026-08-14.

The 52-week high and low of Bandaram Pharma Packtech Ltd. are ₹49.70 and ₹17.45, respectively, as of 2026-08-14.

The dividend yield of Bandaram Pharma Packtech Ltd. is 0.0% as of2026-08-13.

You can buy Bandaram Pharma Packtech Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Bandaram Pharma Packtech Ltd. is B Deepak Reddy.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore